Journal of Invasive Cardiology Editorial Board

Editor-in-Chief:

Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI

Director of Mount Sinai Fuster Heart Hospital

Dr. Valentin Fuster Professor of Cardiovascular Medicine

Icahn School of Medicine at Mount Sinai

Email: DLBhattMD@post.Harvard.edu

LinkedIn: https://www.linkedin.com/in/DLBhattMD

X: https://twitter.com/DLBHATTMD

Instagram: https://www.instagram.com/dlbhattmd/

Facebook: https://www.facebook.com/DLBhattMD/

Disclosures: Dr. Bhatt discloses the following relationships - Advisory Board: Angiowave, Bayer, Boehringer Ingelheim, CellProthera, Cereno Scientific, Elsevier Practice Update Cardiology, High Enroll, Janssen, Level Ex, McKinsey, Medscape Cardiology, Merck, MyoKardia, NirvaMed, Novo Nordisk, PhaseBio, PLx Pharma, Stasys; Board of Directors: American Heart Association New York City, Angiowave (stock options), Bristol Myers Squibb (stock), DRS.LINQ (stock options), High Enroll (stock); Consultant: Broadview Ventures, GlaxoSmithKline, Hims, SFJ, Youngene; Data Monitoring Committees: Acesion Pharma, Assistance Publique-Hôpitaux de Paris, Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute, for the PORTICO trial, funded by St. Jude Medical, now Abbott), Boston Scientific (Chair, PEITHO trial), Cleveland Clinic, Contego Medical (Chair, PERFORMANCE 2), Duke Clinical Research Institute, Mayo Clinic, Mount Sinai School of Medicine (for the ENVISAGE trial, funded by Daiichi Sankyo; for the ABILITY-DM trial, funded by Concept Medical; for ALLAY-HF, funded by Alleviant Medical), Novartis, Population Health Research Institute; Rutgers University (for the NIH-funded MINT Trial); Honoraria: American College of Cardiology (Senior Associate Editor, Clinical Trials and News, ACC.org; Chair, ACC Accreditation Oversight Committee), Arnold and Porter law firm (work related to Sanofi/Bristol-Myers Squibb clopidogrel litigation), Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute; RE-DUAL PCI clinical trial steering committee funded by Boehringer Ingelheim; AEGIS-II executive committee funded by CSL Behring), Belvoir Publications (Editor in Chief, Harvard Heart Letter), Canadian Medical and Surgical Knowledge Translation Research Group (clinical trial steering committees), CSL Behring (AHA lecture), Cowen and Company, Duke Clinical Research Institute (clinical trial steering committees, including for the PRONOUNCE trial, funded by Ferring Pharmaceuticals), HMP Global (Editor in Chief, Journal of Invasive Cardiology), Journal of the American College of Cardiology (Guest Editor; Associate Editor), K2P (Co-Chair, interdisciplinary curriculum), Level Ex, Medtelligence/ReachMD (CME steering committees), MJH Life Sciences, Oakstone CME (Course Director, Comprehensive Review of Interventional Cardiology), Piper Sandler, Population Health Research Institute (for the COMPASS operations committee, publications committee, steering committee, and USA national co-leader, funded by Bayer), WebMD (CME steering committees), Wiley (steering committee); Other: Clinical Cardiology (Deputy Editor); Patent: Sotagliflozin (named on a patent for sotagliflozin assigned to Brigham and Women's Hospital who assigned to Lexicon; neither I nor Brigham and Women's Hospital receive any income from this patent); Research Funding: Abbott, Acesion Pharma, Afimmune, Aker Biomarine, Alnylam, Amarin, Amgen, AstraZeneca, Bayer, Beren, Boehringer Ingelheim, Boston Scientific, Bristol-Myers Squibb, Cardax, CellProthera, Cereno Scientific, Chiesi, CinCor, Cleerly, CSL Behring, Eisai, Ethicon, Faraday Pharmaceuticals, Ferring Pharmaceuticals, Forest Laboratories, Fractyl, Garmin, HLS Therapeutics, Idorsia, Ironwood, Ischemix, Janssen, Javelin, Lexicon, Lilly, Medtronic, Merck, Moderna, MyoKardia, NirvaMed, Novartis, Novo Nordisk, Otsuka, Owkin, Pfizer, PhaseBio, PLx Pharma, Recardio, Regeneron, Reid Hoffman Foundation, Roche, Sanofi, Stasys, Synaptic, The Medicines Company, Youngene, 89Bio; Royalties: Elsevier (Editor, Braunwald’s Heart Disease); Site Co-Investigator: Abbott, Biotronik, Boston Scientific, CSI, Endotronix, St. Jude Medical (now Abbott), Philips, SpectraWAVE, Svelte, Vascular Solutions; Trustee: American College of Cardiology; Unfunded Research: FlowCo.

________________

Editor Emeritus

Richard E. Shaw, PhD, FACC, FACA

California Pacific Medical Center,

San Francisco, California

Founding Editor

Ted Parris, MD

Philadelphia, Pennsylvania

Editorial Board

Kul B. Aggarwal, MD 
Columbia, Missouri

H. Vernon Anderson, MD
Houston, Texas

Robert J. Applegate, MD
Winston-Salem, North Carolina

Thomas Bashore, MD
Durham, North Carolina

Robert M. Bersin, MD, MPH
Seattle, Washington

Rafael Beyar, MD, DSc
Haifa, Israel

James C. Blankenship, MD
Danville, Pennsylvania

Raoul Bonan, MD
Montréal, Québec, Canada

Sorin J. Brener, MD
Brooklyn, New York

Emmanouil Brilakis, MD
Dallas, Texas

Matthew J. Budoff, MD
Los Angeles, California

Blase Carabello, MD
Houston, Texas

Joseph Carrozza Jr, MD
Boston, Massachusetts

Joseph Carver, MD
Philadelphia, Pennsylvania

Mehmet Cilingiroglu, MD
Little Rock, Arkansas

Marc Cohen, MD 
Newark, New Jersey

Todd J. Cohen, MD 
Mineola, New York

Antonio Colombo, MD 
Milan, Italy

George Dangas, MD, PhD
New York, New York

Rajesh Dave, MD
Harrisburg, Pennsylvania

Luis M. de la Fuente, MD
Buenos Aires, Argentina

Joshua De Leon, MD
Mineola, New York

Robert S. Dieter, MD
Maywood, Illinois

Gerald Dorros, MD
Wilson, Wyoming

Franz R. Eberli, MD
Zurich, Switzerland

Kenneth A. Ellenbogen, MD
Richmond, Virginia

Stephen G. Ellis, MD
Cleveland, Ohio

Dmitriy N. Feldman, MD 
New York, New York

Tim Fischell, MD
Kalamazoo, Michigan

Peter J. Fitzgerald, MD
Stanford, California

Lawrence A. Garcia, MD
Boston, Massachusetts

Kirk N. Garratt, MD
New York, New York

Jon C. George, MD
Philadelphia, Pennsylvania

Gregory R. Giugliano, MD
Springfield, Massachusetts

Sheldon Goldberg, MD
Philadelphia, Pennsylvania

Steven L. Goldberg, MD
Kalispell, Montana

Scott Goldman, MD
Wynnewood, Pennsylvania

Anuj Gupta, MD 
Baltimore, Maryland

Harvey S. Hecht, MD 
New York, New York

Tarek Helmy, MD 
St Louis, MO

Ziyad M. Hijazi, MD 
Doha, Qatar

Kalon Ho, MD
Boston, Massachusetts

Paul C. Ho, MD
Honolulu, Hawaii

Dray Song Hong, MD
Taichung, Taiwan

Angela Hoye, MD
Rotterdam, The Netherlands

Deepak Jain, MD
Lübeck, Germany

Navin K. Kapur, MD
Boston, Massachusetts

Dean J. Kereiakes, MD 
Cincinnati, Ohio

Lloyd Klein MD 
Santa Clara, CA

William Knopf, MD 
Atlanta, Georgia

Ronald J. Krone, MD 
St. Louis, Missouri

David P. Lee, MD
Stanford, California

Ronald C. H. Lee, MBBS
Singapore

Michael J. Lim, MD
St. Louis, Missouri

John J. Lopez, MD
Maywood, Illinois

Bruce W. Lytle, MD
Cleveland, Ohio

Shamir R. Mehta, MD 
Hamilton, Ontario, Canada

Marie-Claude Morice, MD 
Antony, France

Srihari S. Naidu, MD 
Mineola, New York

Aravinda Nanjundappa, MD
Cleveland, Ohio

Samir Pancholy, MD 
Scranton, PA

Anand Prasad, MD 
San Antonio, Texas

Jeffrey J. Rade, MD
Worcester, Massachusetts

David R. Ramsdale, MD
Liverpool, United Kingdom

P. Syamasundar Rao, MD
Houston, Texas

Michael R. Recto, MD 
New Orleans, Louisiana

David Rizik, MD
Scottsdale, Arizona

Oscar R. Rosales, MD
Houston, Texas

Habib Samady, MD
Atlanta, Georgia

Satinder K. Sandhu, MD
Miami, Florida

Michael Savage, MD
Philadelphia, Pennsylvania

Patrick W. Serruys, MD, PhD
Rotterdam, The Netherlands

Nicolas Shammas, MD 
Davenport, Iowa

Samin K. Sharma, MD
New York, New York

Michael Sketch, MD
Durham, North Carolina

Zoltan G. Turi, MD
Philadelphia, Pennsylvania

George Vetrovec, MD 
Richmond, Virginia

Ron Waksman, MD 
Washington, D.C.

Craig Walker, MD 
Houma, Louisiana

John G. Webb, MD 
Vancouver, British Colombia

William S. Weintraub, MD 
Atlanta, Georgia

Neil J. Weissman, MD 
Washington, D.C.

Mark H. Wholey, MD
Pittsburgh, Pennsylvania
 
James R. Wilentz, MD
New York, New York
 
Stephan Windecker, MD
Bern, Switzerland

Chunyu Zeng, MD 
Chongqing City, China